183 related articles for article (PubMed ID: 9845590)
1. Effect of multidisciplinary treatment with high dose rate intraluminal brachytherapy on survival in patients with unresectable esophageal cancer.
Iwasa M; Ohmori Y; Iwasa Y; Yamamoto A; Inoue A; Maeda H; Kume M; Ogoshi S; Nishioka A; Ogawa Y; Yoshida S
Dig Surg; 1998; 15(3):227-35. PubMed ID: 9845590
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study.
Sur RK; Levin CV; Donde B; Sharma V; Miszczyk L; Nag S
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):127-33. PubMed ID: 12007950
[TBL] [Abstract][Full Text] [Related]
3. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
Okawa T; Dokiya T; Nishio M; Hishikawa Y; Morita K
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):623-8. PubMed ID: 10524414
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.
Tamaki T; Ishikawa H; Takahashi T; Tamaki Y; Kitamoto Y; Okamoto M; Noda SE; Katoh H; Shirai K; Sakurai H; Nakano T
Brachytherapy; 2012; 11(2):130-6. PubMed ID: 21700506
[TBL] [Abstract][Full Text] [Related]
5. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy.
Sharma V; Mahantshetty U; Dinshaw KA; Deshpande R; Sharma S
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):310-5. PubMed ID: 11872275
[TBL] [Abstract][Full Text] [Related]
6. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.
Sur RK; Donde B; Levin VC; Mannell A
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834
[TBL] [Abstract][Full Text] [Related]
7. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases.
Ghosh S; Sau S; Mitra S; Manna A; Ghosh K
J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668
[TBL] [Abstract][Full Text] [Related]
8. High dose rate brachytherapy for superficial cancer of the esophagus.
Maingon P; d'Hombres A; Truc G; Barillot I; Michiels C; Bedenne L; Horiot JC
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):71-6. PubMed ID: 10656375
[TBL] [Abstract][Full Text] [Related]
9. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center.
Bhatt L; Tirmazy S; Sothi S
Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484
[TBL] [Abstract][Full Text] [Related]
10. New multi-disciplinary treatment modality with RALS for patients with esophageal cancer.
Toki T; Ogoshi S; Ogawa Y; Ohmori Y; Iwasa Y; Iwasa M; Nishioka A
Oncol Rep; 1998; 5(5):1157-62. PubMed ID: 9683827
[TBL] [Abstract][Full Text] [Related]
11. Palliative treatment by high-dose-rate intraluminal brachytherapy in patients with advanced esophageal cancer.
Skowronek J; Piotrowski T; Zwierzchowski G
Brachytherapy; 2004; 3(2):87-94. PubMed ID: 15374540
[TBL] [Abstract][Full Text] [Related]
12. Intraluminal irradiation for T2M0 esophageal cancer: effect of patient selection on prognosis.
Nakajima T; Fukuda H; Hosono M; Tsumura M; Tada T; Nishita T; Tashiro M; Hirokawa K; Onoyama Y
Radiat Med; 1992; 10(3):123-8. PubMed ID: 1509104
[TBL] [Abstract][Full Text] [Related]
13. [High-dose-rate brachytherapy in esophageal carcinoma: the Italian experience].
Gava A; Fontan L; Bolner A; Botturi M; Cafaro I; Di Marco A; Marazzato G; Muto P; Orecchia R; Orsatti M; Parisi SS; Rigon A
Radiol Med; 1996; 91(1-2):118-21. PubMed ID: 8614712
[TBL] [Abstract][Full Text] [Related]
14. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.
Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G
Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150
[TBL] [Abstract][Full Text] [Related]
15. Intracavitary radiation in the treatment of advanced esophageal carcinoma: a comparison of high dose rate vs. low dose rate brachytherapy.
Harvey JC; Fleischman EH; Bellotti JE; Kagan AR
J Surg Oncol; 1993 Feb; 52(2):101-4. PubMed ID: 7682263
[TBL] [Abstract][Full Text] [Related]
16. External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma.
Muijs CT; Beukema JC; Mul VE; Plukker JT; Sijtsema NM; Langendijk JA
Radiother Oncol; 2012 Feb; 102(2):303-8. PubMed ID: 21885139
[TBL] [Abstract][Full Text] [Related]
17. Effective palliation for advanced esophageal cancer using intralumenal irradiation.
Makarewicz R; Czechowicz W; Kabacińska R
Mater Med Pol; 1996; 28(3):107-110. PubMed ID: 9167421
[TBL] [Abstract][Full Text] [Related]
18. Combined external and intraluminal radiotherapy in the treatment of advanced oesophageal cancer.
Hujala K; Sipilä J; Minn H; Ruotsalainen P; Grenman R
Radiother Oncol; 2002 Jul; 64(1):41-5. PubMed ID: 12208574
[TBL] [Abstract][Full Text] [Related]
19. [Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in esophageal cancer].
Patonay P; Naszály A; Mayer A
Strahlenther Onkol; 2007 Feb; 183(2):94-8. PubMed ID: 17294114
[TBL] [Abstract][Full Text] [Related]
20. [Combined radiotherapy for inoperable esophageal cancer].
Kanaev SV; Shcherbakov AM; Shulepov AV
Vopr Onkol; 2006; 52(1):32-7. PubMed ID: 16715700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
